Helixmith Co., Ltd

₩3,465As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:084990Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (23.24%)
Div yield —
ROE (1.17%)
Biotechnology
Beta (5Y) 0.53
PE TTM —
TSR TTM (34.62%)
Mkt cap ₩159.6B
ROIC (13.04%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,107
18.52%
(92.26%)
Hold 5|2|1|4|10
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
58.11
58.83
57.76
58.63
32.81%
21.78%
9.60%
11.32%
Revenue₩B
19.55
19.35
19.29
18.96
2.13%
4.02%
(1.29%)
(4.94%)
Peers (US$117.6M)
Cap (US$)
PE
120.5M
30.07x
117.9M
19.70x
Capital
TTM
5Y
10Y
Leveragex
1.191
0.022
0.022
EBIT/Intx
1.146
0.467
0.426
Own earn%
107.05
(189.88)
(165.17)
Sh yield%
45.33
46.29
46.54
Owners
Insiders/Inst%
4.49
59.65
Short interest%
1.67
SBC / revenue%
4.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
3–6
$1 testx
—
Incr. ROIC%
20